Emerine salicylate oral liquid and its prepn

The present invention discloses one kind of emerine salicylate oral liquid prepared with emerine salicylate, sodium pyrosulfite, citric acid, ethyl hydroxyl benzoate, disodium edentate, etc. Of the emerine salicylate oral liquid, emerine salicylate is atropine antagonist to inhibit central AChE acti...

Full description

Saved in:
Bibliographic Details
Main Author YINGBIAO,CHEN TIAN
Format Patent
LanguageEnglish
Published 22.08.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses one kind of emerine salicylate oral liquid prepared with emerine salicylate, sodium pyrosulfite, citric acid, ethyl hydroxyl benzoate, disodium edentate, etc. Of the emerine salicylate oral liquid, emerine salicylate is atropine antagonist to inhibit central AChE activity and maintain relevant skeletal muscle contractility, citric acid is used to regulate pH to 4.8-5.6, and sodium pyrosulfite and disodium edentate are added to avoid the oxidation and hydrolysis of emerine salicylate. Compared with similar medicine, the emerine salicylate oral liquid of the present invention has the advantages of determined curative effect, less side effect and low cost, and is used in treating bulbar patalysis, cerebrellar ataxia, etc.
Bibliography:Application Number: CN20071200308